David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SASR
2801
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.11M | ﹤0.01% |
59,876
+24,116
| +67% | +$951K |
|
|
BSGA
2802
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
| $2.11M | ﹤0.01% |
205,181
| – | – |
|
2803
CALL
Agnico Eagle Mines
AEM
$109B
| $2.11M | ﹤0.01% |
50,000
-1,900
| -4% | -$81.5K |
|
2804
CALL
STAAR Surgical
STAA
$1.12B
| $2.11M | ﹤0.01% |
29,900
| – | – |
|
|
AERT
2805
Aeries Technology
AERT
$37.1M
| $2.1M | ﹤0.01% |
26,309
+3,393
| +15% | +$270K |
|
2806
Banner Corp
BANR
$2.38B
| $2.1M | ﹤0.01% |
35,631
-16,254
| -31% | -$981K |
|
2807
Littelfuse
LFUS
$10.7B
| $2.1M | ﹤0.01% |
10,596
+2,982
| +39% | +$712K |
|
2808
APi Group
APG
$17.8B
| $2.1M | ﹤0.01% |
237,681
+180,714
| +317% | +$1.93M |
|
|
DQ
2809
PUT
Daqo New Energy
DQ
$923M
| $2.1M | ﹤0.01% |
39,600
| – | – |
|
2810
PUT
Ambarella
AMBA
$3.12B
| $2.1M | ﹤0.01% |
37,400
-39,900
| -52% | -$2.96M |
|
2811
FuboTV Inc
FUBO
$305M
| $2.1M | ﹤0.01% |
49,276
+43,843
| +807% | +$1.88M |
|
2812
Rollins
ROL
$17.3B
| $2.1M | ﹤0.01% |
60,502
-26,953
| -31% | -$972K |
|
2813
CALL
Norfolk Southern
NSC
$78.1B
| $2.1M | ﹤0.01% |
10,000
+5,200
| +108% | +$1.25M |
|
|
2814
PUT
Norfolk Southern
NSC
$78.1B
| $2.1M | ﹤0.01% |
10,000
+6,700
| +203% | +$1.61M |
|
2815
Beam Therapeutics
BEAM
$3.15B
| $2.1M | ﹤0.01% |
+43,995
| New | +$2.51M |
|
2816
TriNet
TNET
$3.19B
| $2.1M | ﹤0.01% |
29,430
-41,049
| -58% | -$3.34M |
|
2817
CALL
Clearfield
CLFD
$407M
| $2.09M | ﹤0.01% |
+20,000
| New | +$1.95M |
|
|
FTPA
2818
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $2.08M | ﹤0.01% |
211,870
| – | – |
|
|
ROCL
2819
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $2.08M | ﹤0.01% |
208,500
| – | – |
|
|
BPMC
2820
DELISTED
Blueprint Medicines
BPMC
| $2.08M | ﹤0.01% |
31,549
-6,298
| -17% | -$405K |
|
2821
CALL
Entegris
ENTG
$22.2B
| $2.08M | ﹤0.01% |
+25,000
| New | +$2.44M |
|
|
2822
PUT
Entegris
ENTG
$22.2B
| $2.08M | ﹤0.01% |
+25,000
| New | +$2.44M |
|
|
LX
2823
LexinFintech Holdings
LX
$191M
| $2.08M | ﹤0.01% |
1,227,695
+3,387
| +0.3% | +$6.81K |
|
2824
CALL
Align Technology
ALGN
$11.3B
| $2.07M | ﹤0.01% |
10,000
-10,100
| -50% | -$2.6M |
|
|
DADA
2825
DELISTED
Dada Nexus
DADA
| $2.07M | ﹤0.01% |
437,884
-86,414
| -16% | -$571K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.